Automation, AI, and human organoids enable researchers to move away from outdated 2D cell cultures and animal models, ...
A phase 2 study evaluates the safety and efficacy of brentuximab vedotin and nivolumab plus chemotherapy in patients with early-stage classical Hodgkin lymphoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results